Eyenovia Competitors and Similar CompaniesClear all

Eyenovia's competitors and similar companies include XVIVO Perfusion, CoapTech, Emulate and Genotypic Technology.

	Eyenovia Eyenovia is a late-stage biopharmaceutical company with three lead programs in glaucoma, mydriasis and dry eye with a transformative ophthalmic delivery platform.	XVIVO Perfusion XVIVO Perfusion is a medical technology company that develops machines and perfusion solutions.	CoapTech CoapTech is a medical device company aiming to improve medical care delivery for patients.	Emulate Emulate is a biotechnology company that specializes in organ-on-chips technology.	Genotypic Technology Genotypic Technology is a company that provides genomics, microarray, bioinformatics and next-generation sequencing (NGS) solutions and services.
Founding Date	Founding Date 2014	Founding Date 1998	Founding Date 2016	Founding Date 2014	Founding Date 1998
Type	Type Public	Type Public	Type Private	Type Private	Type Private
Tags	Tags Healthcare Manufacturing & Industrial biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices	Tags Healthcare Manufacturing & Industrial biotech healthtech medical devices platform	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices
Locations	Locations New York, US HQ	Locations Mölndal, SE HQ Shanghai, CN Novegro Tregarezzo, IT Groningen, NL Lund, SE Mölndal, SE Aurora, US see more	Locations Baltimore, US HQ	Locations Boston, US HQ	Locations Bengaluru, IN HQ
Employees	Employees 22100% increase	Employees 19320% increase	Employees 2717% increase	Employees 802% decrease	Employees 1146% increase
Valuation ($)	Valuation ($) 47.3 m	Valuation ($) 1.4 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $813.5k (FY, 2025)	Revenue (est.) kr812.2m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $303.3k (FY, 2025)	Cost of goods kr208.5m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $510.2k (FY, 2025)	Gross profit kr605.4m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income ($45.3m) (FY, 2025)	Net income kr25.2m (FY, 2025)	Net income N/A	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 1.2m (over 6 years ago)	Latest funding round $ 36m (almost 8 years ago)	Latest funding round N/A
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 3.6m	Total funding raised $ 95m	Total funding raised N/A